CRP and COVID-19: Cytokine therapy, on the other hand, is able to inhibit viral replication (131, 132) For example, interferon-α2b treatment displayed a positive response in COVID-19 patients, resulting in a shortened duration of viral shedding and downregulation of markers of acute inflammation such as C-reactive protein and interleukin-6 (IL-6) (133).